Akums Drugs & Pharma Quarterly Results for Trading Insights
AKUMS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹43 Cr
QSept 2025
Akums Drugs & Pharma Quarterly Results Key Highlights
- Revenue of ₹1,050 Cr in Sept 2025 (-2.9% vs Mar 2025, +0.0% vs Sept 2024)
- Net Profit of ₹43 Cr in Sept 2025 (-71.3% vs Mar 2025, -35.8% vs Sept 2024)
- EBITDA of ₹127 Cr in Sept 2025 (+5.8% vs Mar 2025)
- Operating Margin of 9.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹2.66 in Sept 2025 (-72.4% vs Mar 2025)
Akums Drugs & Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,050 | 1,081 | 1,051 | 1,194 | 1,050 | -2.9% | - |
| Net Profit (₹ Cr) | 43 | 150 | 65 | 68 | 67 | - | - |
| EBITDA (₹ Cr) | 127 | 120 | 156 | 163 | 138 | - | - |
| EPS (₹) | 2.66 | 9.64 | 4.15 | 4.33 | 4.37 | - | - |
| Operating Margin (%) | 9.0% | 9.0% | 13.0% | 11.0% | 12.0% | - | - |
Akums Drugs & Pharma Share Price Trend Around Quarterly Results
Visualize Akums Drugs & Pharma's 1-year price movement across quarterly results — ideal for logging trades in Akums Drugs & Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Akums Drugs & Pharma
Additional stock information and data for AKUMS
Revenue Trend (₹ Cr)
Dec 2025
1,194
Jun 2025
1,051
Mar 2025
1,081
Sept 2025
1,050
Net Profit Trend (₹ Cr)
Dec 2025
68
Jun 2025
65
Mar 2025
150
Sept 2025
43
Operating Margin Trend (%)
Dec 2025
11.0%
Jun 2025
13.0%
Mar 2025
9.0%
Sept 2025
9.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Akums Drugs & Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1801.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 138.6 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6071.0 | 2,860 | 689 | +7.1% | - | 24.1% | 233.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4390.0 | 3,219 | 591 | +11.3% | - | 18.4% | 250.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1292.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1314.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores